Unmet needs in basic and translational research in Cholangiocarcinoma
Liver Cancer International · 2022
DOI: 10.1002/lci2.39 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer International, 2022. Verfasst von Massimiliano Cadamuro und 6 weiteren Autor:innen. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Cooperation in Science and Technology, Fundació la Marató de TV3, Junta de Castilla y León.
Abstract (Originalsprache)
Background and Aims Despite the impact of cutting‐edge technologies in providing deep molecular phenotyping of many tumours, management of cholangiocarcinoma (CCA), a rare and insufficiently studied cancer with marked heterogeneity (including intrahepatic and extrahepatic variants), has remained limited and it has poor prognosis. Renewed interest in this enigmatic disease has been fostered in the last decade. Here, we will give an overview of the most important gaps in knowledge of the basic and translational research of CCA that must be prioritized to improve the CCA management in the future.
Methods
Exploration was initially conducted on the Consensus Statement on Cholangiocarcinoma 2020, where after careful discussion of priorities, basic/translational research were selected and approved. Then, systematic literature searches using PubMed were performed by authors from different disciplines to highlight the most relevant areas requiring further study.
Results
Genetic and molecular characterization studies have identified the presence of actionable mutations in both intrahepatic (50%‐60%) and extrahepatic CCA (25%), but efficacy of targeted interventions is still hindered by several factors. They include a limited understanding of the intricate mechanisms of pharmacoresistance, the lack of accurate biomarkers enabling early detection of the disease, the complex role of the tumour microenvironment exerting both tumour‐promoting and tumour‐restraining functions, and the inadequacy of experimental models to recapitulate the wide heterogeneity of these tumours.
Conclusions
Promoting international collaborations among scientists with multidisciplinary skills, and creation of platforms to collect data and biological samples of patients from different countries are the actions needed to understand better in this still challenging disease.
Förderung
- European Cooperation in Science and Technology
- Fundació la Marató de TV3
- Junta de Castilla y León
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Zitieren
APA
Cadamuro, M., Macias, R. I., Strain, A. J., Strazzabosco, M., Simioni, P., Marin, J. J., & Fabris, L. (2022). Unmet needs in basic and translational research in Cholangiocarcinoma. Liver Cancer International. https://doi.org/10.1002/lci2.39
Vancouver
Cadamuro M, Macias RI, Strain AJ, Strazzabosco M, Simioni P, Marin JJ, et al. Unmet needs in basic and translational research in Cholangiocarcinoma. Liver Cancer International. 2022. doi:10.1002/lci2.39
BibTeX
@article{Cadamuro2022,
author = {Cadamuro, Massimiliano and Macias, Rocio I.R. and Strain, Alastair J. and Strazzabosco, Mario and Simioni, Paolo and Marin, Jose J.G. and Fabris, Luca},
title = {Unmet needs in basic and translational research in Cholangiocarcinoma},
journal = {Liver Cancer International},
year = {2022},
doi = {10.1002/lci2.39}
}
EUVIMED